AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. SATO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Depreciation & amortization

SATO PHARMACEUTICAL CO.,LTD.【JP:E00954】

Market cap
P/E ratio
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndDepreciation & amortization (Million JPY)YoY (%)
Jul 31, 20231,641-7.03%
Jul 31, 20221,765+15.89%
Jul 31, 20211,523+0.93%
Jul 31, 20201,509-1.69%
Jul 31, 20191,535-9.71%
Jul 31, 20181,700-7.15%
Jul 31, 20171,831+17.90%
Jul 31, 20161,553-0.77%
Jul 31, 20151,565+6.32%
Jul 31, 20141,472

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)